Dentsply Sirona Inc. · NASDAQ:XRAY
Dentsply Sirona — Q3 2025 Earnings Presentation
20 slides from Dentsply Sirona's earnings presentation, Nov 6, 2025
Slide 1: Third Quarter 2025 Earnings Conference Call
Third Quarter 2025 November 6, 2025 Earnings Conference Call
Slide 2: Forward-Looking Statements and Associated Risks
Forward-Looking Statements and Associated Risks All statements in this Presentation that do not directly and exclusively relate to historical facts constitute "forward-looking statements." Such statements are subject to numerous assumptions, risks, uncertainties and other factors that could cause ac
Slide 3: First 90 Days
First 90 Days Listening and learning deep-dives with customers, partners, and employees Validated initial observations and identified strengths and areas of improvement Aligning leadership team with additional skills and expertise to drive the business forward Developed and executing Return-To-Growt
Slide 4: Third Quarter 2025 Financial Summary
Third Quarter 2025 Financial Summary Q3 2025 Q3 2024 YoY Commentary ▪ Net sales in constant currency (8.0%) YoY, Net Sales $904M $951M (5.0%) including (5.5%) driven by Q3 2024 Byte impact and ERP pre-buy(1) • Declines in EDS, CTS, and OIS, partially Constant offset by Wellspect (8.0%) 1.3% (930) bp
Slide 5: Summary of Q3 Results
Summary of Q3 Results Net Sales Adj. EBITDA Margin Adj. EPS $904M 18.4% $0.37 (8.0%) 50 bps (26.5%) Constant Currency YoY Increase YoY Decline YoY including (5.5%) driven by Q3 2024 Byte impact and ERP pre-buy(1) Constant Currency (18.3%) (7.7%) Byte U.S. Net Sales Europe Net Sales impact Rest of Wo
Slide 6: Third Quarter 2025 Segment Results
Third Quarter 2025 Segment Results Sales Commentary Connected ▪ CAD/CAM (DD): Lower volumes in U.S. and Rest of World Technology $259M Solutions Reported: (3.9%) ▪ Equipment & Instruments +LSD: Imaging and treatment center volume growth in Europe and Constant Currency: (7.0%) (CTS) Rest of World, pa
Slide 7: Revised 2025 Outlook
Revised 2025 Outlook* Prior Outlook Current Outlook Constant Currency (4.0%) to (2.0%) (5%) to (4%) Reported Sales $3.60B - $3.70B $3.6B - $3.7B Adjusted EBITDA Margin >19% >18% Adjusted EPS $1.80 - $2.00 ~$1.60 Constant currency, adjusted EBITDA margin, and adjusted EPS are Non-GAAP measures as def
Slide 8: Return-to-Growth Action Plan
Return-to-Growth Action Plan 1 2 3 4 Putting Customers Reigniting the U.S. Empowering People Evolving Operations at the Center Business to Win to Power Performance to Fuel Innovation • Establishing new Global • Aligning commercial • Building high-performing, • Accelerating investments Customer Servi
Slide 9: In Summary
In Summary “ Moving with urgency and speed Executing Return-to-Growth action plan Focusing on delivering sustained, profitable growth over the next 24 months 9
Slide 10: Appendix
Appendix Dentsply S Sirona
Slide 11: Trailing Nine Quarters
Trailing Nine Quarters In millions (except percentages) Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Net Sales $947 $1,012 $953 $984 $951 $905 $879 $936 $904 Adjusted EBITDA(1) $171 $173 $160 $173 $170 $128 $168 $197 $167 Adj. EBITDA Margin %(1) 18.3% 17.1% 16.8% 17.5% 17.9% 14.2% 19.0% 21.
Slide 12: Non-GAAP Financial Measures Definitions
Non-GAAP Financial Measures Definitions Constant Currency Adjusted Gross Profit and Margin The Company defines "constant currency" as the reported net sales adjusted for the impact of foreign currency Adjusted gross profit is computed by excluding from gross profit the impact of any of the above adj
Slide 13: Net Sales to Constant Currency Basis by Segment
Reconciliation of Non-GAAP Financial Measures Net Sales to Constant Currency Basis by Segment (unaudited) 13
Slide 14: Net Sales to Constant Currency Basis by Geographic Region
Reconciliation of Non-GAAP Financial Measures Net Sales to Constant Currency Basis by Geographic Region (unaudited) 14
Slide 15: Segment Adjusted Operating Income
Reconciliation of Non-GAAP Financial Measures Segment Adjusted Operating Income (unaudited) 15
Slide 16: Condensed Consolidated Statements of Operations Q3 2025
Reconciliation of Non-GAAP Financial Measures Condensed Consolidated Statements of Operations Q3 2025 (unaudited) 16
Slide 17: Condensed Consolidated Statements of Operations Q3 2024
Reconciliation of Non-GAAP Financial Measures Condensed Consolidated Statements of Operations Q3 2024 (unaudited) 17
Slide 18: Adjusted EBITDA Q3 2025 and Q3 2024
Reconciliation of Non-GAAP Financial Measures Adjusted EBITDA Q3 2025 and Q3 2024 (unaudited) 18
Slide 19: Adjusted Free Cash Flow and Calculation of Adjusted Free Cash Flow Conversion
Reconciliation of Non-GAAP Financial Measures Adjusted Free Cash Flow and Calculation of Adjusted Free Cash Flow Conversion (unaudited) 19
Slide 20: Slide 20